Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.7 - $3.0 $85,680 - $367,200
-122,400 Reduced 55.71%
97,300 $102,000
Q2 2022

Aug 12, 2022

BUY
$0.75 - $5.6 $116,775 - $871,920
155,700 Added 243.28%
219,700 $165,000
Q1 2022

May 13, 2022

BUY
$3.3 - $7.28 $211,200 - $465,920
64,000 New
64,000 $339,000

Others Institutions Holding EAR

About Eargo, Inc.


  • Ticker EAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 39,411,000
  • Market Cap $2.78B
  • Description
  • Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...
More about EAR
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.